IRIS Accounts Production v25.1.3.33 05774959 Board of Directors 1.10.23 30.9.24 30.9.24 9.7.25 false true false false true false Auditors Opinion Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh057749592023-09-30057749592024-09-30057749592023-10-012024-09-30057749592022-09-30057749592022-10-012023-09-30057749592023-09-3005774959ns15:EnglandWales2023-10-012024-09-3005774959ns14:PoundSterling2023-10-012024-09-3005774959ns10:Director12023-10-012024-09-3005774959ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3005774959ns10:SmallEntities2023-10-012024-09-3005774959ns10:Audited2023-10-012024-09-3005774959ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3005774959ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3005774959ns10:FullAccounts2023-10-012024-09-3005774959ns10:Director22023-10-012024-09-3005774959ns10:CompanySecretary12023-10-012024-09-3005774959ns10:RegisteredOffice2023-10-012024-09-3005774959ns5:CurrentFinancialInstruments2024-09-3005774959ns5:CurrentFinancialInstruments2023-09-3005774959ns5:Non-currentFinancialInstruments2024-09-3005774959ns5:Non-currentFinancialInstruments2023-09-3005774959ns5:ShareCapital2024-09-3005774959ns5:ShareCapital2023-09-3005774959ns5:FurtherSpecificReserve1ComponentTotalEquity2024-09-3005774959ns5:FurtherSpecificReserve1ComponentTotalEquity2023-09-3005774959ns5:RetainedEarningsAccumulatedLosses2024-09-3005774959ns5:RetainedEarningsAccumulatedLosses2023-09-3005774959ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3005774959ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3005774959ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-09-3005774959ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-09-3005774959ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-09-3005774959ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-09-3005774959ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-09-3005774959ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-09-3005774959ns5:Secured2024-09-3005774959ns5:Secured2023-09-30
REGISTERED NUMBER: 05774959 (England and Wales)














LOTUS MEDICAL ESTATES LIMITED

AUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024






LOTUS MEDICAL ESTATES LIMITED (REGISTERED NUMBER: 05774959)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 30 September 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


LOTUS MEDICAL ESTATES LIMITED

COMPANY INFORMATION
for the Year Ended 30 September 2024







DIRECTORS: A K Sahdev
D Ratneswaran





SECRETARY: A K Sahdev





REGISTERED OFFICE: 5 Imperial Court
Laporte Way
Luton
Bedfordshire
LU4 8FE





REGISTERED NUMBER: 05774959 (England and Wales)





AUDITORS: Miller & Co
Statutory Auditor
Chartered Accountants
5 Imperial Court
Laporte Way
Luton
Bedfordshire
LU4 8FE

LOTUS MEDICAL ESTATES LIMITED (REGISTERED NUMBER: 05774959)

STATEMENT OF FINANCIAL POSITION
30 September 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Investment property 5 4,000,000 5,000,000

CURRENT ASSETS
Debtors 6 29,660 10,109
Cash at bank 17,693 28,599
47,353 38,708
CREDITORS
Amounts falling due within one year 7 485,510 394,818
NET CURRENT LIABILITIES (438,157 ) (356,110 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,561,843

4,643,890

CREDITORS
Amounts falling due after more than one
year

8

2,422,187

2,498,466
NET ASSETS 1,139,656 2,145,424

CAPITAL AND RESERVES
Called up, paid and allotted share capital 200 200
Non-distributable reserves 182,286 1,182,286
Retained earnings 957,170 962,938
SHAREHOLDERS' FUNDS 1,139,656 2,145,424

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 July 2025 and were signed on its behalf by:





A K Sahdev - Director


LOTUS MEDICAL ESTATES LIMITED (REGISTERED NUMBER: 05774959)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 30 September 2024

1. STATUTORY INFORMATION

Lotus Medical Estates Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling, rounded to the nearest pound.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Financial instruments
Derivative financial instruments are recognised at fair value using a valuation technique with any gains or losses being reported in profit or loss.

Taxation
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of timing differences. Deferred tax on revalued non-depreciable tangible fixed assets and investment properties is measured using the rates and allowances that apply to the sale of the asset.

Going concern
The accounts have been prepared on the going concern basis which is considered appropriate by the directors. The company has been financially supported by loans from the bank and the directors. The company is operating within its banking facilities and will continue to be supported financially by the directors.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

LOTUS MEDICAL ESTATES LIMITED (REGISTERED NUMBER: 05774959)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 September 2024

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 October 2023 5,000,000
Revaluations (1,000,000 )
At 30 September 2024 4,000,000
NET BOOK VALUE
At 30 September 2024 4,000,000
At 30 September 2023 5,000,000

Investment property was valued on an open market basis by the directors.

If investment properties had not been revalued they would have been included at historical cost totalling £3,817,714.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 7,228 3,235
Other debtors 22,432 6,874
29,660 10,109

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 66,122 60,879
Derivative financial liability 334,649 231,276
Trade creditors 158 4,751
Tax - 14,183
VAT 2,637 2,545
Other creditors 227 227
Directors' current accounts 51,900 51,900
Accrued expenses 29,817 29,057
485,510 394,818

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans - 1-2 years 69,428 63,923
Bank loans - 2-5 years 229,816 211,593
Bank loans more than 5 years 2,122,943 2,222,950
2,422,187 2,498,466

LOTUS MEDICAL ESTATES LIMITED (REGISTERED NUMBER: 05774959)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 September 2024

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
2024 2023
£    £   
Amounts falling due in more than five years:

Repayable by instalments
Bank loans more than 5 years 2,122,943 2,222,950

9. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loans 2,488,309 2,559,345

10. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

S Healy (Senior Statutory Auditor)
for and on behalf of Miller & Co

11. RELATED PARTY DISCLOSURES

Loan Accounts
The directors operate loan accounts with the company. At the year end, the directors were owed £51,900.